RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,522 | -58.5% | 1,174 | -66.0% | 0.00% | – |
| Q2 2023 | $8,482 | +9878.8% | 3,448 | -90.8% | 0.00% | – |
| Q1 2023 | $85 | -33.6% | 37,635 | +3.0% | 0.00% | – |
| Q4 2022 | $128 | -100.0% | 36,543 | +0.8% | 0.00% | -100.0% |
| Q3 2022 | $1,342,000 | +111.3% | 36,263 | +8.5% | 0.00% | +100.0% |
| Q2 2022 | $635,000 | +9.1% | 33,435 | +55.1% | 0.00% | 0.0% |
| Q1 2022 | $582,000 | +65.8% | 21,559 | +38.3% | 0.00% | – |
| Q4 2021 | $351,000 | -15.4% | 15,584 | -1.5% | 0.00% | -100.0% |
| Q3 2021 | $415,000 | -14.4% | 15,826 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $485,000 | -15.9% | 15,153 | -7.6% | 0.00% | 0.0% |
| Q1 2021 | $577,000 | +5.1% | 16,393 | -4.3% | 0.00% | 0.0% |
| Q4 2020 | $549,000 | -8.8% | 17,128 | +7.1% | 0.00% | 0.0% |
| Q3 2020 | $602,000 | -24.6% | 15,998 | -10.3% | 0.00% | 0.0% |
| Q2 2020 | $798,000 | – | 17,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |